Safety, tolerability, pharmacokinetics and pharmacodynamics of losmapimod following a single intravenous or oral dose in healthy volunteers

AIMS: The purpose of this study was to establish safety and tolerability of a single intravenous (IV) infusion of a p38 mitogen-activated protein kinase inhibitor, losmapimod, to obtain therapeutic levels rapidly for a potential acute coronary syndrome indication. Pharmacokinetics (PK) following IV...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Barbour, April M, Sarov-Blat, Lea, Cai, Gengqian, Fossler, Michael J, Sprecher, Dennis L, Graggaber, Johann, McGeoch, Adam T, Maison, Jo, Cheriyan, Joseph
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Blackwell Science Inc 2013
Gaiak:
Pharmacokinetic Dynamic Relationships
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC3703232/
https://ncbi.nlm.nih.gov/pubmed/23215699
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/bcp.12063
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak